Business

July 14, 2014

Salix gets good news from FDA on Relistor drug application

Salix Pharmaceuticals announced Monday that federal regulators have signaled they will approve its drug Relistor for treatment of chronic pain in non-cancer patients.

Related content

Comments

Videos

Editor's Choice Videos